LEIA SULLIVAN: Open Payments
NPI 1104679240 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 61 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $865 · 2025 $1,619
Food & beverage: $1,520Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $678 |
| Janssen Biotech, Inc. | 5 | $325 |
| Phathom Pharmaceuticals, Inc. | 9 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 5 | $76 |
| Madrigal Pharmaceuticals | 2 | $74 |
| Ardelyx, Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $61 |
| GENZYME CORPORATION | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
Products named: SKYRIZI, TREMFYA, VOQUEZNA, CREON, RINVOQ, ENTYVIO, ZENPEP, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
